Glucose Regulation

Blood Glucose Regulation

  • Blood glucose concentration is continually monitored and adjusted to maintain metabolic homeostasis.

  • Regulation depends primarily on two peptide hormones synthesized in the pancreatic islets of Langerhans:

    • Glucagon

    • Secreted by pancreatic α-cells when blood glucose is low.

    • Binds to a membrane receptor that couples to the same GsG_s (stimulatory G-protein) pathway activated by epinephrine.

    • Activates adenylate cyclase → ↑ cAMPcAMP → activation of protein kinase A (PKA) → phosphorylation cascade that stimulates glycogen breakdown (glycogenolysis) and gluconeogenesis.

    • Insulin

    • Secreted by pancreatic β-cells when blood glucose is high.

    • Promotes:

      • Glucose uptake in muscle, liver, and adipose tissue (via translocation of GLUT4 transporters in muscle & adipose; up-regulation of glucokinase in liver).

      • Glycogen synthesis (glycogenesis) by activating glycogen synthase and inhibiting glycogen phosphorylase.

    • Net effect = decrease blood glucose concentration.

Diabetes Mellitus (General Overview)

  • Defined as chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both.

  • Presents with characteristic signs & symptoms often remembered as the “3 P’s”:

    • Polyuria (frequent urination)

    • Polydipsia (excessive thirst)

    • Polyphagia (excessive hunger)

  • Additional manifestations: unexplained weight loss, fatigue, blurred vision, slow wound healing, susceptibility to infections.

  • Long-term complications (micro- & macro-vascular): nephropathy, neuropathy, retinopathy, cardiovascular disease, stroke, peripheral vascular disease.

Major Types of Diabetes Mellitus (Preview)

  • Type 1 Diabetes (T1D)

    • Autoimmune destruction of pancreatic β-cells → absolute insulin deficiency.

    • Typically develops in childhood or adolescence but can occur at any age.

    • Patients require lifelong exogenous insulin therapy.

  • Type 2 Diabetes (T2D)

    • Characterized by insulin resistance (decreased tissue responsiveness) combined with a relative insulin secretory defect.

    • Strongly associated with obesity, sedentary lifestyle, and genetic predisposition.

    • Management: lifestyle modification, oral hypoglycemic agents, and/or insulin.

Why Hyperglycemia Produces Classic Symptoms (Physiological Rationale)

  • Polyuria: When plasma glucose > renal threshold (≈ 10 mmol⋅L−110\,\text{mmol·L}^{-1} or 180 mg⋅dL−1180\,\text{mg·dL}^{-1}), excess glucose is excreted in urine (glycosuria) creating an osmotic diuresis → ↑ urine volume.

  • Polydipsia: Fluid loss through polyuria triggers hypothalamic thirst centers → excessive water intake.

  • Polyphagia: Despite hyperglycemia, cells are starving for glucose (due to lack of insulin or resistance) → signals of energy deficiency to hypothalamus.

Connections & Context

  • Epinephrine vs. Glucagon: Both hormones activate glycogen breakdown via the same GsG_s / cAMPcAMP / PKA pathway, but epinephrine is secreted by adrenal medulla in response to stress, whereas glucagon responds specifically to low glucose.

  • Insulin Signaling (Coming Up): Will contrast with glucagon by utilizing a receptor tyrosine kinase (RTK) mechanism, initiating cascades (e.g., PI3K/Akt) that favor anabolic processes.

  • Clinical Relevance: Precise coordination of insulin and glucagon prevents extreme fluctuations in blood glucose; failure in this system underlies both acute metabolic crises (e.g., diabetic ketoacidosis) and chronic complications.